Abstract
Data on the efficacy of antipsychotics as monotherapy for obsessive-compulsive disorder (OCD) are inadequate. This report presents the case of a patient with OCD that was successfully treated with risperidone as monotherapy. Assessments revealed significant reductions in OCD symptoms after risperidone treatment (4 mg/d). This report suggests the beneficial effect of risperidone for a patient with OCD comorbid with schizoaffective disorder.
Original language | English |
---|---|
Pages (from-to) | 114-116 |
Number of pages | 3 |
Journal | Clinical Neuropharmacology |
Volume | 38 |
Issue number | 3 |
DOIs | |
State | Published - 30 05 2015 |
Bibliographical note
Publisher Copyright:© 2015 Wolters Kluwer Health, Inc. All rights reserved.
Keywords
- obsessive compulsive disorder
- risperidone